The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Hyloris Pharmaceuticals SA announced that Maxigesic® IV has been approved for the relief of mild to moderate pain and for the management of moderate ...
read more
Enable Injections announced that the FDA approved the EMPAVELI Injector (enFuse®) for the subcutaneous delivery of EMPAVELI® (pegcetacoplan), which is...
read more
Thursday, September 28, 2023
HitGen announced a partnership with The Structural Genomics Consortium ("SGC"), a public-private partnership that supports the discovery of new ...
read more
Wednesday, September 06, 2023
XtalPi, a provider of AI-powered drug discovery solutions, and Parthenon Therapeutics, a clinical-stage biotechnology company dedicated to ...
read more
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA (long-acting) capsules,60 ...
read more
UPMC announced a collaboration with PharmaLogic Holdings Corp. to facilitate the development of novel radiopharmaceuticals for the diagnosis and ...
read more
ANNEXA-I, a post-marketing Phase IV trial to assess the efficacy and safety of Andexxa (andexanet alfa) in patients on oral FXa-inhibitor treatment ...
read more
The FDA has approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-...
read more
Biomea Fusion, Inc announced that the FDA cleared the Investigational New Drug (IND) application to begin a Phase I trial (COVALENT-103) of BMF-500, ...
read more
Premier Research announced the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) ...
read more
PerkinElmer announced that it has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses ...
read more
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of cancer, ...
read more
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry, with focus on the bio-...
read more
Eli Lilly and Company announced that the FDA approved an expanded indication for Verzenio® (abemaciclib), in combination with endocrine therapy (ET), ...
read more
Sitero is pleased to announce the addition of Jeff Huntsman to its growing leadership team as Chief Commercial Officer. Jeff brings over 30 years of ...
read more